U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
3474134741CVI Drug Coated Balloon First In Human TrialCompletedNo Results AvailablePeripheral Arterial DiseaseDevice: Percutaneous Transluminal Angioplastyhttps://ClinicalTrials.gov/show/NCT02110524
3474234742Body Responses to Bean Physical Form and "Beano"CompletedNo Results AvailableAppetite and Glucose ResponsesOther: blended lentils|Other: whole lentils|Other: no lentilshttps://ClinicalTrials.gov/show/NCT02110511
3474334743Early Detection of Pancreatic Cystic NeoplasmsRecruitingNo Results AvailablePancreatic Cysts|Intraductal Papillary Mucinous Neoplasm|Pancreatic Mucinous-Cystic Neoplasm|Cystic, Mucinous and/or Serous Neoplasm|Solid Pseudopapillary Tumour of the Pancreashttps://ClinicalTrials.gov/show/NCT02110498
3474434744Randomized Controlled Trial of a Patient Activation Tool in Pediatric Appendicitis (Antibiotics Alone vs. Appendectomy)RecruitingNo Results AvailableAppendicitis|ChildrenOther: Patient Activation Toolhttps://ClinicalTrials.gov/show/NCT02110485
3474534745Investigation of the Presbia Flexivue Microlensâ„¢Active, not recruitingNo Results AvailablePresbyopiaDevice: Corneal inlayhttps://ClinicalTrials.gov/show/NCT02110472
3474634746Pharmacokinetics and Safety of POL7080 in Patients With Renal ImpairmentRecruitingNo Results AvailableRenal ImpairmentDrug: POL7080https://ClinicalTrials.gov/show/NCT02110459
3474734747Evaluation of the Efficacy and the Mechanism of Chinese Herbal Formula SS-1 for Sjögren's SyndromeRecruitingNo Results AvailableSjögren's SyndromeDrug: SS-1|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02110446
3474834748Heart Failure Educational and Follow up PlatformRecruitingNo Results AvailableChronic Heart FailureDevice: Placebo group|Device: Cordiva System (R)|Device: BNP heartcheckhttps://ClinicalTrials.gov/show/NCT02110433
3474934749First-in-human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of CC-90001CompletedNo Results AvailableHealthy VolunteersDrug: CC-90001|Drug: CC-90001|Drug: CC-90001|Drug: CC-90001|Drug: CC-90001|Drug: CC-90001|Drug: CC-90001|Drug: CC-90001|Drug: CC-90001|Drug: CC-90001|Drug: Placebo|Drug: CC-90001|Drug: CC-90001|Drug: CC-90001https://ClinicalTrials.gov/show/NCT02110420
3475034750Modulation of Visual-Spatial Learning in Healthy Young Adults by tDCSRecruitingNo Results AvailableHealthy Young AdultsDevice: tDCS|Behavioral: traininghttps://ClinicalTrials.gov/show/NCT02110407
3475134751Ribomustin in the First Line Therapy of Chronic Lymphocytic LeukemiaActive, not recruitingNo Results AvailableChronic Lymphocytic LeukemiaOther: bendamustine|Other: rituximabhttps://ClinicalTrials.gov/show/NCT02110394
3475234752Assessing Alternative Approaches for Blood Pressure Control: A3BC TrialRecruitingNo Results AvailableHypertensionDevice: Device guided breathing RESPeRATE|Device: Isometric hand grip Zona Plushttps://ClinicalTrials.gov/show/NCT02110381
3475334753Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting ConditionsCompletedNo Results AvailablePrimary Hypogonadism|Hypogonadotropic HypogonadismDrug: Testosterone Topical Gel, 1.62% Metered Pump|Drug: AndroGel (testosterone gel) 1.62% Metered-Dose Pumphttps://ClinicalTrials.gov/show/NCT02110368
3475434754A Phase 1b/2a Study Evaluating AMG 232 in Metastatic MelanomaRecruitingNo Results AvailableAdvanced Malignancy|Advanced Solid Tumors|Cancer|Oncology|Oncology Patients|Tumors|MelanomaDrug: AMG 232|Drug: Trametinib|Drug: Dabrafenibhttps://ClinicalTrials.gov/show/NCT02110355
3475534755A Study To Understand How Radiolabelled PF-04449913 Is Taken Up By The Body, Broken Down And Then Removed From The BodyCompletedNo Results AvailableHealthyDrug: [14C] PF-04449913https://ClinicalTrials.gov/show/NCT02110342
3475634756Simultaneaous Detection of Quantitative Somatic Alterations Using the Qantitative Multiplex Pcr of Short Fluorescent Fragments Method (QMPSF) in Stage II-III Colon Cancer: a Prospective StudyCompletedNo Results AvailableColorectal Cancer|Stage II and IIIGenetic: evaluation of the recurrence rate according to molecular analysishttps://ClinicalTrials.gov/show/NCT02110329
3475734757Bioavailability of VoriconazoleRecruitingNo Results AvailableVoriconazole|Bioavailability|Critically IllOther: Dosage form of voriconazolehttps://ClinicalTrials.gov/show/NCT02110316
3475834758DIAMOND - Dual Antiplatelet Therapy to Reduce Myocardial InjuryRecruitingNo Results AvailableCoronary Artery DiseaseDrug: Ticagrelor|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02110303
3475934759Effects of an Adapted Ski/Snowboarding Program on Quality of Life in Children With Physical DisabilitiesEnrolling by invitationNo Results AvailableCerebral Palsy|Traumatic Brain Injuries|Spinal Cord Injuries|Physical Disabilityhttps://ClinicalTrials.gov/show/NCT02110290
3476034760Photoacoustic Imaging of the OvaryRecruitingNo Results AvailableOvarian CancerDevice: PAI/ultrasound Diagnostic Grouphttps://ClinicalTrials.gov/show/NCT02110277
3476134761Injectable Pharmacotherapy for Opioid Use Disorders (IPOD)Not yet recruitingNo Results AvailableOpioid Use DisordersDrug: XR-NTX|Behavioral: XR-NTX+PN|Behavioral: ETAUhttps://ClinicalTrials.gov/show/NCT02110264
3476234762Exercise Therapy With Risk Factor Management and Life Style Coaching After Vascular Intervention for Patients With Peripheral Arterial DiseaseRecruitingNo Results AvailablePeripheral Arterial Disease, Rutherford Stage 4 and 5 With the Possibility to Improve Vascularization.Behavioral: Supervised Exercise Therapyhttps://ClinicalTrials.gov/show/NCT02110251
3476334763Non-Inferiority Study Comparing 3 Weekly Injections of SUPARTZ® vs 3 Weekly Injections of Euflexxa® for Knee OACompletedNo Results AvailableOsteoarthritisDevice: Supartz, 2.5 ml unit dose|Device: Euflexxa, 2 ml unit dosehttps://ClinicalTrials.gov/show/NCT02110238
3476434764A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP)Active, not recruitingNo Results AvailableRetinitis PigmentosaDrug: rhNGF 60 µg/ml eye drops solution|Drug: rhNGF 180 µg/ml eye drops solution|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02110225
3476534765Femtosecond Laser for Cataract SurgeryTerminatedNo Results AvailableCataractProcedure: U/S Surgery and CCC|Device: FS Laser Surgeryhttps://ClinicalTrials.gov/show/NCT02110212
3476634766Lumbar Intervertebral Disc HerniationRecruitingNo Results AvailableLumbar Disc HerniationDevice: Dynamic Stabilization|Procedure: Discectomy|Device: Instrumentation and fusionhttps://ClinicalTrials.gov/show/NCT02110186
347673476718F-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET/CT) For The Evaluation Of Response To Therapy In Bone-Dominant Metastatic Breast CancerRecruitingNo Results AvailableBone Dominant Metastatic ER+ Breast CancerDevice: FDG PET/CT|Biological: Fluorodeoxyglucose F 18 Injection (FDG)https://ClinicalTrials.gov/show/NCT02110160
3476834768Open-Label Study of Uridine Triacetate in Pediatric Patients With Hereditary Orotic AciduriaActive, not recruitingNo Results AvailableHereditary Orotic AciduriaDrug: uridine triacetatehttps://ClinicalTrials.gov/show/NCT02110147
3476934769A Study of the RevLite Laser System for the Treatment of Refractory Mixed Type MelasmaCompletedNo Results AvailableMelasmaDevice: Revlite Laser Systemhttps://ClinicalTrials.gov/show/NCT02110134
3477034770Picosure Alexandrite Laser and Revlite Nd:Yag Laser for the Treatment of Unwanted TattoosActive, not recruitingNo Results AvailableUnwanted TattoosDevice: Picosure Laser System|Device: Revlite Laser Systemhttps://ClinicalTrials.gov/show/NCT02110121

* Görseller ve İçerik tekif hakkına sahip olabilir